GlassScriptPhysician profile
Robert C Galban
NPI 1124593728
$4,127.61
in general payments reported to CMS, 2019-2025
14 companies · $556 in 2025
The $556 reported for 2025 was more than what 80% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,138 · 2020: $85.32 · 2021: $151 · 2022: $305 · 2023: $542 · 2024: $350 · 2025: $556.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,358 · Entertainment: $90.98.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,357.76 |
| Entertainment | $90.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Surgical Vision, INC. | $807.39 | 2019 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $767.85 | 2019-2021 | |
| Bausch & Lomb Americas INC. | $767.05 | 2022-2025 | Infuse, Miebo, Xiidra |
| Johnson & Johnson Vision Care, INC. | $360.24 | 2019-2025 | Acuvue |
| Biotissue Holdings INC. | $312.61 | 2021-2023 | |
| Alcon Vision LLC | $285.17 | 2019-2025 | Precision7, Total30 |
| Sun Pharmaceutical Industries INC. | $229.90 | 2019-2025 | |
| Coopervision INC. | $177.50 | 2019-2023 | Misight Contact Lens |
| Dompe US, INC. | $131.48 | 2022-2023 | Oxervate |
| Optos, INC. | $90.98 | 2025 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Maculogix, INC. | $76.35 | 2019 | |
| Shire North American Group INC | $65.96 | 2019 | |
| Oasis Medical, INC. | $43.75 | 2022 | |
| Abb Con-Cise Optical Group LLC | $11.38 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Galban listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.